A patient ordering medication online probably doesn’t spend much time thinking about the financial machinery behind the purchase.
The payment either goes through or it doesn’t.
For a healthcare business, the situation is considerably more complicated. An online pharmacy or telehealth platform must navigate payment processing, banking relationships, recurring billing, transaction disputes and an unusually sensitive regulatory environment.
Those financial issues are familiar territory for Derik Fay.
Through 3F Management, the entrepreneur has built a portfolio spanning several industries, including financial services and payment processing. Its business interests include Tycoon Payments, a payment-processing company identified on 3F’s website as co-owned by the firm.
Now Fay is applying that background to a very different market.
His latest venture, RX Management Systems, operates in the GLP-1 and peptide healthcare sector. But the business opportunity he describes goes beyond the medication itself.
The real challenge, in his view, is developing the infrastructure required to support an increasingly complex healthcare category.
Why Healthcare Is Also a Payments Story
Financial institutions don’t evaluate every business in the same way.
An online retailer selling household goods presents one risk profile. A business handling prescriptions, sensitive healthcare products and recurring patient payments presents another.
Banks and processors must consider the nature of the products being sold, the legitimacy of the operating model, regulatory exposure, customer disputes and their own compliance obligations.
The result can be a difficult environment for businesses that are growing quickly while operating in a closely scrutinized category.
Fay’s experience in payments provides a useful lens for understanding the problem.
In fintech, much of the complexity is invisible to the customer. A seemingly simple transaction depends on multiple organizations working together. When one part of that system becomes unreliable, every other part is affected.
Healthcare has a similar structure.
A patient may encounter a doctor through a digital platform, receive a prescription, complete a payment and wait for medication to arrive. Behind that experience are separate clinical, pharmaceutical, financial and logistical responsibilities.
Those responsibilities cannot simply be combined without regard for healthcare law. But they can be coordinated through better management, technology and clearly defined operating relationships.
That is the larger opportunity Fay is pursuing.
From Tycoon Payments to RX Management Systems
The connection between 3F Management’s payments interests and Fay’s healthcare venture is strategic rather than merely technological.
RX Management Systems has not announced that it is becoming a payment processor or developing a cryptocurrency product. Its stated business centers on pharmacy relationships, fulfillment, operational management, compliance and acquisitions.
Nevertheless, Fay’s fintech background shapes the questions he brings to the sector.
Where do transactions encounter friction? Which functions depend too heavily on outside providers? What does a financial institution need to see before it becomes comfortable working with a business? And how can a company develop systems that support growth without creating unmanageable risk?
These are questions that matter in payment processing and healthcare alike.
They also matter to future investors and potential acquirers, who are likely to examine the reliability of a company’s revenue, operating relationships and regulatory exposure as carefully as its growth rate.
Where Crypto Fits, and Where It Doesn’t
Cryptocurrency provides an interesting comparison, although not necessarily a business model for RX.
Early digital-asset businesses frequently encountered difficulty establishing conventional banking relationships. As the industry developed, financial institutions began creating more specialized approaches to payments, custody, underwriting and compliance.
Healthcare is dealing with a different set of products and regulations, but the general lesson is relevant: consumer demand can accelerate before the institutions supporting an industry have fully adapted.
That does not mean stablecoins or blockchain are required to solve GLP-1 payments.
Nor does it mean RX Management Systems currently operates a digital-asset platform.
For now, Fay’s fintech angle is more practical. His experience in payments helps him understand the financial friction surrounding a growing healthcare market, while his M&A background informs how he approaches the broader operating business.
The patient may see a prescription.
Fay sees the network of businesses, financial relationships and regulatory responsibilities required to deliver it.
